Powered by

Dana-Farber Cancer Institute: Novel Targeted Drug Shows Promise in Advanced Kidney Cancer

Feb 17, 2020 - Targeted News Service

The Dana-Farber Cancer Institute issued the following news release:

Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.

Researchers from Dana-Farber Cancer Institute report a response rate of 24 percent across all risk categories of patients given an oral first-in-class agent that targets hypoxia-inducible factor (HIF) 2-a, which promotes new blood vessel growth that f...